Emergent (EBS) Provides Update on DoD Anthrax Vaccine, Cancels Request for Proposal
http://www.streetinsider.com/Corporate+News/Emergent+(EBS)+Provides+Update+on+DoD+Anthrax+Vaccine,+Cancels+Request+for+Proposal/3101397.html
Emergent BioSolutions Inc. (NYSE: EBS) has been advised that the U.S. Department of Defense intends to pursue a collaborative arrangement with the U.S. Department of Health and Human Services to facilitate the use by DoD of stockpiled doses of BioThrax to prevent future waste of government funding and resources and that DoD is therefore cancelling its previously announced request for proposal.
Emergent BioSolutions Inc. (NYSE: EBS) has been advised that the U.S. Department of Defense intends to pursue a collaborative arrangement with the U.S. Department of Health and Human Services to facilitate the use by DoD of stockpiled doses of BioThrax to prevent future waste of government funding and resources and that DoD is therefore cancelling its previously announced request for proposal.
